Masataka Goto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Masataka Goto has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Kentaro Koide
Department of Bacteriology II, National Institute of Infectious Diseases, Japan Institute for Health Security
3 shared publications - Nao Otsuka
Department of Bacteriology II, National Institute of Infectious Diseases, Japan Institute for Health Security
3 shared publications - Tsuyoshi Kenri
Department of Bacteriology II, National Institute of Infectious Diseases
2 shared publications - Hidetoshi Takada
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan
1 shared publication - Hiromichi Suzuki
Department of Infectious Diseases, University of Tsukuba Hospital, Tsukuba, Japan
1 shared publication Kaoru Ikeda
Department of Pediatrics, National Defense Medical College
1 shared publication
Latest Publications
- Open Access
- 7 July 2026
- Published by American Society for Microbiology in ASM Case Reports
- Vol. 2 (4)
Co-infection with macrolide-resistant and macrolide-susceptible Bordetella pertussis strains in an infant: a case report
Background: Bordetella pertussis infection causes severe respiratory illness, particularly in young infants. Although macrolides are recommended as the first-line treatment, macrolide-resistant strains have emerged in several countries. In Japan, a nationwide pertussis epidemic occurred in 2025, during which numerous infections were reported not only due to macrolide-susceptible B. pertussis (MSBP) but also due to macrolide-resistant strains (MRBP). Case Summary: A 2-month-old female developed a persistent cough and was admitted to the pediatric intensive care unit (PICU), where she received frequent suctioning and short-term high-flow nasal cannula therapy. BioFire FilmArray Respiratory Panel 2.1 analysis of her nasal swab detected B. pertussis DNA; azithromycin was therefore administered for 5 days. Direct sequencing of the DNA extracted from her nasal swabs initially indicated an A2047G mutation in the 23S rRNA gene of B. pertussis, indicating MRBP infection, although the electropherogram was unclear. Trimethoprim-sulfamethoxazole was initiated on day 8 of her PICU stay following confirmation of MRBP infection. Subsequently, bacterial culture yielded two different B. pertussis strains, which were confirmed as MRBP and MSBP through antimicrobial susceptibility testing. Multilocus variable-number tandem-repeat analysis and whole-genome analysis demonstrated that the strains were genetically unrelated. The patient was discharged and subsequently fully recovered after a 14 day course of trimethoprim-sulfamethoxazole. Conclusion: To our knowledge, this is the first confirmed case of co-infection with MRBP and MSBP strains. Such mixed infections may be missed by the diagnostic methods currently used in clinical practice, highlighting the importance of careful interpretation of test results.
- 7 July 2026
- Published by American Society for Microbiology in ASM Case Reports
- Vol. 2 (4)
Open AccessCo-infection with macrolide-resistant and macrolide-susceptible Bordetella pertussis strains in an infant: a case report
Background: Bordetella pertussis infection causes severe respiratory illness, particularly in young infants. Although macrolides are recommended as the first-line treatment, macrolide-resistant strains have emerged in several countries. In Japan, a nationwide pertussis epidemic occurred in 2025, during which numerous infections were reported not only due to macrolide-susceptible B. pertussis (MSBP) but also due to macrolide-resistant strains (MRBP). Case Summary: A 2-month-old female developed a persistent cough and was admitted to the pediatric intensive care unit (PICU), where she received frequent suctioning and short-term high-flow nasal cannula therapy. BioFire FilmArray Respiratory Panel 2.1 analysis of her nasal swab detected B. pertussis DNA; azithromycin was therefore administered for 5 days. Direct sequencing of the DNA extracted from her nasal swabs initially indicated an A2047G mutation in the 23S rRNA gene of B. pertussis, indicating MRBP infection, although the electropherogram was unclear. Trimethoprim-sulfamethoxazole was initiated on day 8 of her PICU stay following confirmation of MRBP infection. Subsequently, bacterial culture yielded two different B. pertussis strains, which were confirmed as MRBP and MSBP through antimicrobial susceptibility testing. Multilocus variable-number tandem-repeat analysis and whole-genome analysis demonstrated that the strains were genetically unrelated. The patient was discharged and subsequently fully recovered after a 14 day course of trimethoprim-sulfamethoxazole. Conclusion: To our knowledge, this is the first confirmed case of co-infection with MRBP and MSBP strains. Such mixed infections may be missed by the diagnostic methods currently used in clinical practice, highlighting the importance of careful interpretation of test results.
- 9 May 2025
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (7) , 102727
Fatal case of macrolide-resistant Bordetella pertussis infection, Japan, 2024
- 9 May 2025
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (7) , 102727
Fatal case of macrolide-resistant Bordetella pertussis infection, Japan, 2024
- 15 January 2024
- Published by Wiley in Microbiology and Immunology
- Vol. 68 (3) , 111-114
Strain identity of Bordetella pertussis isolates from household members based on whole‐genome sequencing
We evaluated the genetic diversity of Bordetella pertussis, the causative agent of pertussis, within households by whole‐genome sequencing. In pairwise comparisons of 23 isolates collected from 11 households, single‐nucleotide polymorphism (SNP) analysis revealed extremely low SNP diversity (≤1 SNP) between isolate pairs: no SNPs were detected in 10 households and one SNP was obtained in the remaining household. This SNP was uncommon for B. pertussis and resulted in a nonsynonymous substitution (Ala303Thr) in nicotinate phosphoribosyltransferase. We demonstrated that the same strain is transmitted between household members and that B. pertussis is genomically stable during household transmission.
- 15 January 2024
- Published by Wiley in Microbiology and Immunology
- Vol. 68 (3) , 111-114
Strain identity of Bordetella pertussis isolates from household members based on whole‐genome sequencing
We evaluated the genetic diversity of Bordetella pertussis, the causative agent of pertussis, within households by whole‐genome sequencing. In pairwise comparisons of 23 isolates collected from 11 households, single‐nucleotide polymorphism (SNP) analysis revealed extremely low SNP diversity (≤1 SNP) between isolate pairs: no SNPs were detected in 10 households and one SNP was obtained in the remaining household. This SNP was uncommon for B. pertussis and resulted in a nonsynonymous substitution (Ala303Thr) in nicotinate phosphoribosyltransferase. We demonstrated that the same strain is transmitted between household members and that B. pertussis is genomically stable during household transmission.